Cargando…
Molecular forms of neurogranin in cerebrospinal fluid
Neurogranin (Ng) is a 78 amino acid neuronal protein and a biomarker candidate for Alzheimer's disease (AD). Ng has been suggested to bind to calmodulin and phosphatidic acid via its centrally located IQ domain. Ng is cleaved within this functionally important domain, yielding the majority of f...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378242/ https://www.ncbi.nlm.nih.gov/pubmed/33249594 http://dx.doi.org/10.1111/jnc.15252 |
_version_ | 1783740800506527744 |
---|---|
author | Nazir, Faisal Hayat Camporesi, Elena Brinkmalm, Gunnar Lashley, Tammaryn Toomey, Christina E. Kvartsberg, Hlin Zetterberg, Henrik Blennow, Kaj Becker, Bruno |
author_facet | Nazir, Faisal Hayat Camporesi, Elena Brinkmalm, Gunnar Lashley, Tammaryn Toomey, Christina E. Kvartsberg, Hlin Zetterberg, Henrik Blennow, Kaj Becker, Bruno |
author_sort | Nazir, Faisal Hayat |
collection | PubMed |
description | Neurogranin (Ng) is a 78 amino acid neuronal protein and a biomarker candidate for Alzheimer's disease (AD). Ng has been suggested to bind to calmodulin and phosphatidic acid via its centrally located IQ domain. Ng is cleaved within this functionally important domain, yielding the majority of fragments identified in cerebrospinal fluid (CSF), suggesting that cleavage of Ng may be a mechanism to regulate its function. Up to now, Ng has been shown to be present in CSF as both C‐terminal fragments as well as full‐length protein. To obtain an overview of the different molecular forms of Ng present in CSF, we show by size exclusion chromatography (SEC), immunoblotting, immunoprecipitation, and MS that Ng is present in CSF as several molecular forms. Besides monomeric full‐length Ng, also higher molecular weight forms of Ng, and C‐terminal‐ and previously not identified N‐terminal fragments were observed. We found by immunodepletion that C‐terminal peptides contribute on average to ~50% of the total‐Ng ELISA signal in CSF samples. There were no differences in the overall C‐terminal fragment/total‐Ng ratios between samples from AD and control groups. In addition, we found that monomeric Ng and its C‐terminal fragments bind to heparin via a heparin‐binding motif, which might be of relevance for their export mechanism from neurons. Taken together, this study highlights the presence of several molecular forms of Ng in CSF, comprising monomeric full‐length Ng, and N‐ and C‐terminal truncations of Ng, as well as larger forms of still unknown composition. [Image: see text] |
format | Online Article Text |
id | pubmed-8378242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83782422021-08-27 Molecular forms of neurogranin in cerebrospinal fluid Nazir, Faisal Hayat Camporesi, Elena Brinkmalm, Gunnar Lashley, Tammaryn Toomey, Christina E. Kvartsberg, Hlin Zetterberg, Henrik Blennow, Kaj Becker, Bruno J Neurochem ORIGINAL ARTICLES Neurogranin (Ng) is a 78 amino acid neuronal protein and a biomarker candidate for Alzheimer's disease (AD). Ng has been suggested to bind to calmodulin and phosphatidic acid via its centrally located IQ domain. Ng is cleaved within this functionally important domain, yielding the majority of fragments identified in cerebrospinal fluid (CSF), suggesting that cleavage of Ng may be a mechanism to regulate its function. Up to now, Ng has been shown to be present in CSF as both C‐terminal fragments as well as full‐length protein. To obtain an overview of the different molecular forms of Ng present in CSF, we show by size exclusion chromatography (SEC), immunoblotting, immunoprecipitation, and MS that Ng is present in CSF as several molecular forms. Besides monomeric full‐length Ng, also higher molecular weight forms of Ng, and C‐terminal‐ and previously not identified N‐terminal fragments were observed. We found by immunodepletion that C‐terminal peptides contribute on average to ~50% of the total‐Ng ELISA signal in CSF samples. There were no differences in the overall C‐terminal fragment/total‐Ng ratios between samples from AD and control groups. In addition, we found that monomeric Ng and its C‐terminal fragments bind to heparin via a heparin‐binding motif, which might be of relevance for their export mechanism from neurons. Taken together, this study highlights the presence of several molecular forms of Ng in CSF, comprising monomeric full‐length Ng, and N‐ and C‐terminal truncations of Ng, as well as larger forms of still unknown composition. [Image: see text] John Wiley and Sons Inc. 2020-12-17 2021-05 /pmc/articles/PMC8378242/ /pubmed/33249594 http://dx.doi.org/10.1111/jnc.15252 Text en © 2020 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | ORIGINAL ARTICLES Nazir, Faisal Hayat Camporesi, Elena Brinkmalm, Gunnar Lashley, Tammaryn Toomey, Christina E. Kvartsberg, Hlin Zetterberg, Henrik Blennow, Kaj Becker, Bruno Molecular forms of neurogranin in cerebrospinal fluid |
title | Molecular forms of neurogranin in cerebrospinal fluid |
title_full | Molecular forms of neurogranin in cerebrospinal fluid |
title_fullStr | Molecular forms of neurogranin in cerebrospinal fluid |
title_full_unstemmed | Molecular forms of neurogranin in cerebrospinal fluid |
title_short | Molecular forms of neurogranin in cerebrospinal fluid |
title_sort | molecular forms of neurogranin in cerebrospinal fluid |
topic | ORIGINAL ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378242/ https://www.ncbi.nlm.nih.gov/pubmed/33249594 http://dx.doi.org/10.1111/jnc.15252 |
work_keys_str_mv | AT nazirfaisalhayat molecularformsofneurograninincerebrospinalfluid AT camporesielena molecularformsofneurograninincerebrospinalfluid AT brinkmalmgunnar molecularformsofneurograninincerebrospinalfluid AT lashleytammaryn molecularformsofneurograninincerebrospinalfluid AT toomeychristinae molecularformsofneurograninincerebrospinalfluid AT kvartsberghlin molecularformsofneurograninincerebrospinalfluid AT zetterberghenrik molecularformsofneurograninincerebrospinalfluid AT blennowkaj molecularformsofneurograninincerebrospinalfluid AT beckerbruno molecularformsofneurograninincerebrospinalfluid |